AbstractThe conformational nature of the B cell epitopes on the hepadnavirus surface antigens makes its characterization difficult. Here, a new approach by DNA vaccination with plasmids expressing chimeric hepadnavirus surface antigens was explored to determine B cell epitopes on the surface antigens of woodchuck hepatitis virus (WHsAg). A series of chimeric genes consisting of complementary fragments of WHsAg and hepatitis B virus surface antigens (HBsAg) was constructed. These plasmids expressed the following: (i) middle chimeric surface antigens (MCSAgs), including pre-S2 region and small surface antigens; (ii) small chimeric surface antigens (CSAgs); (iii) a mutated WHsAg with two amino acid substitutions, the Leu 136 to Thr and Ala 140...
AbstractMutant hepatitis B virus with substitutions within the coding region for HBV surface antigen...
To control hepatitis B virus (HBV) infection, a universal HBV vaccination program for infants was la...
A therapeutic vaccine against chronic hepatitis B virus (HBV) infection requires the development of ...
AbstractThe conformational nature of the B cell epitopes on the hepadnavirus surface antigens makes ...
AbstractInsertion of foreign oligopeptide sequences (40–50 amino acids in length) into the Pro144 po...
Hepatitis B virus (HBV) infection is a global burden on the health-care system and is considered as ...
We developed an immunogen to stimulate multivalent immunity against hepatitis B surface antigen (HBs...
Hepatitis B virus (HBV) infection is a global burden on the health-care system and is considered as ...
The repetitive structure of compact virus-like particles (VLPs) provides high density displays of an...
Although hepatitis B surface antigen (HBsAg) per se is highly immunogenic, its use as a vector for t...
The particulate form of the core antigen of hepatitis B virus (HBcAg), is highly immunogenic. It has...
AbstractT helper type 1 (Th1) immunity was considered to play a dominant role in viral clearance of ...
AbstractWe propose the replacement of endogenous epitopes with foreign epitopes to exploit the highl...
The small envelope of hepatitis B virus (HBV) can self-assembles into virus-like particles (VLPs) an...
AbstractWe identified the epitopes on the preS1 which induce antibodies that neutralize both ad and ...
AbstractMutant hepatitis B virus with substitutions within the coding region for HBV surface antigen...
To control hepatitis B virus (HBV) infection, a universal HBV vaccination program for infants was la...
A therapeutic vaccine against chronic hepatitis B virus (HBV) infection requires the development of ...
AbstractThe conformational nature of the B cell epitopes on the hepadnavirus surface antigens makes ...
AbstractInsertion of foreign oligopeptide sequences (40–50 amino acids in length) into the Pro144 po...
Hepatitis B virus (HBV) infection is a global burden on the health-care system and is considered as ...
We developed an immunogen to stimulate multivalent immunity against hepatitis B surface antigen (HBs...
Hepatitis B virus (HBV) infection is a global burden on the health-care system and is considered as ...
The repetitive structure of compact virus-like particles (VLPs) provides high density displays of an...
Although hepatitis B surface antigen (HBsAg) per se is highly immunogenic, its use as a vector for t...
The particulate form of the core antigen of hepatitis B virus (HBcAg), is highly immunogenic. It has...
AbstractT helper type 1 (Th1) immunity was considered to play a dominant role in viral clearance of ...
AbstractWe propose the replacement of endogenous epitopes with foreign epitopes to exploit the highl...
The small envelope of hepatitis B virus (HBV) can self-assembles into virus-like particles (VLPs) an...
AbstractWe identified the epitopes on the preS1 which induce antibodies that neutralize both ad and ...
AbstractMutant hepatitis B virus with substitutions within the coding region for HBV surface antigen...
To control hepatitis B virus (HBV) infection, a universal HBV vaccination program for infants was la...
A therapeutic vaccine against chronic hepatitis B virus (HBV) infection requires the development of ...